Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic ...
Pirtobrutinib significantly improved progression-free survival in untreated CLL/SLL patients compared to standard chemoimmunotherapy in the BRUIN CLL-313 trial. Early trends suggest potential overall ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results